Bio-Rad Laboratories, Inc. ( BIO) - Key Metrics
BIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $24.34 | $13.89 | $3.69 | $2.49 |
| 2026Q1 | $21.96 | -$19.55 | $4.01 | $2.90 |
| 2025Q4 | $25.70 | $26.69 | $6.11 | $4.42 |
| 2025Q3 | $24.25 | -$12.70 | $4.49 | $3.31 |
| 2025Q2 | $23.93 | $11.67 | $4.28 | $2.60 |
BIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 4.23% | 5.28 |
| 2026Q1 | -6.32% | -3.56 |
| 2025Q4 | 0% | 2.84 |
| 2025Q3 | 0% | -5.52 |
| 2025Q2 | 0% | 5.17 |
BIO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.85% | 0.20% |
| 2026Q1 | 1.04% | 0.44% |
| 2025Q4 | 1.46% | 0% |
| 2025Q3 | 1.18% | 0% |
| 2025Q2 | 1.08% | 0% |
BIO
Price: $356.26
52 week price:
Payout Ratio Range:
Earnings Per Share: 8.26 USD
P/E Ratio: 42.92
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 92800
Ebitda: 79.8 millionMarket Capitalization: 9.5 billion